SEC Form SC 13D/A filed by Aziyo Biologics Inc. (Amendment)

10/6/23 3:28:19 PM ET

$AZYO

Medical Specialities

Health Care

Get the next $AZYO alert in real time by email

SC 13D/A 1 tm2327986d1_sc13da.htm SC 13D/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

Elutia Inc.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

05479K106

(CUSIP Number)

W. Matthew Zuga

36 Church Lane

Westport, CT 06880

(646) 793-3510

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

September 21, 2023

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Capital, L.P.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

48,931

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

48,931

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 48,931
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3%
14.	TYPE OF REPORTING PERSON (see instructions) PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners, L.P.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

53,818

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

53,818

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 53,818
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3%
14.	TYPE OF REPORTING PERSON (see instructions) PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners QP, L.P.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

4,001,428

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

4,001,428

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,001,428
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 21.3%
14.	TYPE OF REPORTING PERSON (see instructions) PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners GP, LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

4,813,673

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

4,813,673

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,813,673
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 25.6%
14.	TYPE OF REPORTING PERSON (see instructions) OO (Limited Liability Company)

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners GP, L.P.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

4,813,673

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

4,813,673

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,813,673
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 25.6%
14.	TYPE OF REPORTING PERSON (see instructions) PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Co-Investment Vehicle I, LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

499,145

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

499,145

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 499,145
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.7%
14.	TYPE OF REPORTING PERSON (see instructions) OO (Limited Liability Company)

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Co-Investment Vehicle II, LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

259,282

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

259,282

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 259,282
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.4%
14.	TYPE OF REPORTING PERSON (see instructions) OO (Limited Liability Company)

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Capital, LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

48,931

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

48,931

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 48,931
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3%
14.	TYPE OF REPORTING PERSON (see instructions) OO (Limited Liability Company)

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners II, L.P.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

86,613⁽¹⁾

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

86,613⁽¹⁾

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 86,613⁽¹⁾
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.5%
14.	TYPE OF REPORTING PERSON (see instructions) PN

(1)

Includes: (a) 43,659 shares of Class A Common Stock directly owned, and (b) 42,954 shares of Class A Common Stock issuable upon exercise of Common Warrants purchased pursuant to that certain Securities Purchase Agreement, dated September 21, 2023.

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners QP II, L.P.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

4,151,015⁽¹⁾

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

4,151,015⁽¹⁾

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,151,015⁽¹⁾
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 22.1%
14.	TYPE OF REPORTING PERSON (see instructions) PN

(1)

Includes:(a) 2,092,392 shares of Class A Common Stock directly owned, and (b) 2,058,623 shares of Class A Common Stock issuable upon exercise of Common Warrants purchased pursuant to that certain Securities Purchase Agreement, dated September 21, 2023.

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners GP II, L.P.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

7,827,821

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

7,827,821

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,827,821
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 41.7%
14.	TYPE OF REPORTING PERSON (see instructions) PN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) HighCape Partners GP II, LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

7,827,821

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

7,827,821

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,827,821
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 41.7%
14.	TYPE OF REPORTING PERSON (see instructions) OO (Limited Liability Company)

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Elutia PIPE Investment, LP
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware, United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

3,590,193⁽¹⁾

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

3,590,193⁽¹⁾

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,590,193⁽¹⁾
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 19.1%
14.	TYPE OF REPORTING PERSON (see instructions) PN

(1)

Includes: (a) 1,436,077 shares of Class A Common Stock directly owned, and (b) 2,154,116 shares of Class A Common Stock issuable upon exercise of Common Warrants, purchased pursuant the Securities Purchase Agreement, dated September 21, 2023.

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) W. Matthew Zuga
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

SHARED VOTING POWER

12,690,425

SOLE DISPOSITIVE POWER

10.

SHARED DISPOSITIVE POWER

12,690,425

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,690,425
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 67.5%
14.	TYPE OF REPORTING PERSON (see instructions) IN

1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kevin Rakin
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)        ¨ (b)        ¨
3.	SEC USE ONLY
4.	SOURCE OF FUNDS (see instructions) OO
5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6.	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

SOLE VOTING POWER

90,807

SHARED VOTING POWER

12,690,425

SOLE DISPOSITIVE POWER

90,807

10.

SHARED DISPOSITIVE POWER

12,690,425

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,781,232
12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¨
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 68.0%
14.	TYPE OF REPORTING PERSON (see instructions) IN

EXPLANATORY NOTES

This Amendment No. 2 to Schedule 13D (this “Amendment No. 2”) amends and supplements the Schedule 13D originally filed with the United States Securities and Exchange Commission (the “SEC”) on December 8, 2021 (as amended, the “Schedule 13D”), relating to the shares of Class A Common Stock, par value $0.001 per share (the “Class A Common Stock”) of Elutia Inc., a Delaware corporation (the “Issuer”). Capitalized terms used herein without definition shall have the meaning set forth in the Schedule 13D.

Item 2.

Identity and Background.

Item 2 of the Schedule 13D is hereby amended and restated in its entirety as follows:

The Schedule 13D is being filed by the following persons (each a “Reporting Person” and collectively, the “Reporting Persons”):

HighCape Capital, L.P.

HighCape Partners, L.P.

HighCape Partners QP, L.P.

HighCape Partners GP, LLC

HighCape Partners GP, L.P.

HighCape Co-Investment Vehicle I, LLC

HighCape Co-Investment Vehicle II, LLC

HighCape Capital, LLC

HighCape Partners II, L.P.

HighCape Partners QP II, L.P.

HighCape Partners GP II, L.P.

HighCape Partners GP II, LLC

Elutia PIPE Investment, LP

W. Matthew Zuga

Kevin Rakin

Each of the Reporting Persons, except for Messrs. Zuga and Rakin, is organized under the laws of the State of Delaware. Each of Messrs. Zuga and Rakin is a citizen of the United States. The principal business address of the Reporting Persons is 36 Church Lane, Westport, CT 06880. The Reporting Persons are principally engaged in the business of managing their investments in the securities of the Issuer.

During the last five years, none of the Reporting Persons (i) has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 3. Source or Amount of Funds or Other Consideration.

Item 3 of the Schedule 13D is hereby amended and supplemented by inserting the following information at the end of Item 3:

On September 21, 2023, in connection with the Issuer’s private placement, HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment LP purchased an aggregate of 2,837,128 Common Units (as defined below) from the Issuer at a purchase price of $1.4275 per Common Unit.

The Reporting Persons obtained the funds used to acquire their interests in the Issuer’s securities through capital contributions from their partners and members.

Item 4. Purpose of the Transaction.

Item 4 of the Schedule 13D is hereby amended and supplemented by inserting the following information at the end of Item 4:

Purchase Agreement

On September 21, 2023 (the “Closing Date”), pursuant to that certain Securities Purchase Agreement, dated as of September 18, 2023 (the “Purchase Agreement”), by and among HighCape Partners II, L.P., HighCape Partners QP II, L.P., Elutia PIPE Investment, LP, and certain other investors named therein (collectively, the “Investors”) and the Issuer, the Investors purchased an aggregate of 6,852,811 units (the “Common Units”) from the Issuer, each Common Unit comprised of (a) one share of the Issuer’s Class A common stock, par value $0.001 per share (“Class A Common Stock”) and (b) a warrant (a “Common Warrant”) to purchase one and one half shares of the Issuer’s Class A Common Stock (the “Offering”). The Common Units were sold at a purchase price of $1.4275 per unit. Each Common Warrant is exercisable at any time until the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the Issuer’s CanGaroo®RM antibiotic-eluting biologic envelope or (b) five years from the Closing Date, each at an exercise price per share of $1.4275. As a result of the Offering, (i) HighCape Partners II, L.P. acquired 28,636 shares of Class A Common Stock and 42,954 Common Warrants, (ii) HighCape Partners QP II, L.P. acquired 1,372,415 shares of Class A Common Stock and 2,058,623 Common Warrants, and (iii) Elutia PIPE Investment, LP acquired 1,436,077 shares of Class A Common Stock and 2,154,116 Common Warrants.

Registration Rights Agreement

On September 21, 2023, in connection with the Purchase Agreement, the Issuer and Investors entered into a Registration Rights Agreement (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Issuer agreed to prepare and file a registration statement with the SEC within 60 days after the Closing Date, for purposes of registering the resale of the Class A Common Stock issued in the Offering and the shares of Class A Common Stock issuable upon exercise of the Common Warrants issued in the Offering, and any shares of Class A Common Stock issued as a dividend or other distribution with respect to, in exchange for or in replacement of the Class A Common Stock or the Common Warrants. The Issuer agreed to use commercially reasonable efforts to cause such registration statement to be declared effective by the SEC within 90 days after the Closing Date, or 115 days after the Closing Date if the SEC reviews the registration statement.

The foregoing descriptions of the Purchase Agreement and Registration Rights Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Purchase Agreement and Registration Rights Agreement, which are incorporated as Exhibit 2 and Exhibit 3 to this Amendment No. 2, respectively, and incorporated herein by reference.

General

The Reporting Persons acquired the securities described in this Amendment No. 2 for investment purposes and intend to review the investments in the Issuer on a continuing basis. Any actions the Reporting Persons might undertake may be made at any time and from time to time without prior notice and will be dependent upon the Reporting Persons’ review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer’s business, financial condition, operations and prospects; price levels of the Issuer’s securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments.

The Reporting Persons, subject to certain provisions of the law, may acquire additional securities of the Issuer, or retain or sell all or a portion of the securities then held, in the open market or in privately negotiated transactions. In addition, the Reporting Persons may engage in discussions with management, the board of directors, and stockholders of the Issuer and other relevant parties or encourage, cause or seek to cause the Issuer or such persons to consider or explore extraordinary corporate transactions, such as: a merger, reorganization or take-private transaction that could result in the de-listing or de-registration of the Class A Common Stock; sales or acquisitions of assets or businesses; changes to the capitalization or dividend policy of the Issuer; or other material changes to the Issuer’s business or corporate structure, including changes in management or the composition of the board of directors.

Item 5. Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

(a) – (b)

The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by each of the Reporting Persons, as well as the number of shares of Class A Common Stock as to which each Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition of, or shared power to dispose or to direct the disposition of, based on 18,789,252 shares of Class A Common Stock outstanding as of September 21, 2023, as provided by the Issuer:

								Shared		Sole power		Shared
						Sole power		power to		to dispose		power to
	Amount					to vote or		vote or to		or to direct		dispose or to
	beneficially		Percent			to direct		direct the		the		direct the
Reporting Person	owned		of class			the vote		vote		disposition		disposition
HighCape Capital, L.P.		48,931		0.3	%		0		48,931		0		48,931
HighCape Partners, L.P.		53,818		0.3	%		0		53,818		0		53,818
HighCape Partners QP, L.P.		4,001,428		21.3	%		0		4,001,428		0		4,001,428
HighCape Partners GP, LLC		4,813,673		25.6	%		0		4,813,673		0		4,813,673
HighCape Partners GP, L.P.		4,813,673		25.6	%		0		4,813,673		0		4,813,673
HighCape Co-Investment Vehicle I, LLC		499,145		2.7	%		0		499,145		0		499,145
HighCape Co-Investment Vehicle II, LLC		259,282		1.4	%		0		259,282		0		259,282
HighCape Capital, LLC		48,931		0.3	%		0		48,931		0		48,931
HighCape Partners II, L.P.		86,613		0.5	%		0		86,613		0		86,613
HighCape Partners QP II, L.P.		4,151,015		22.1	%		0		4,151,015		0		4,151,015
HighCape Partners GP II, L.P.		7,827,821		41.7	%		0		7,827,821		0		7,827,821
HighCape Partners GP II, LLC		7,827,821		41.7	%		0		7,827,821		0		7,827,821
Elutia PIPE Investment, LP		3,590,193		19.1	%		0		3,590,193		0		3,590,193
W. Matthew Zuga		12,690,425		67.5	%		0		12,690,425		0		12,690,425
Kevin Rakin		12,781,232		68.0	%		90,807		12,690,425		90,807		12,690,425

Kevin Rakin and W. Matthew Zuga are the managing members of HighCape Partners GP, LLC, which is the general partner of HighCape Partners GP, L.P., which is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. Messrs. Rakin and Zuga are the managing members of HighCape Capital, LLC, which is the general partner of HighCape Capital, L.P. Messrs. Rakin and Zuga are also the managing members of HighCape Partners GP II, LLC, which is the general partner of HighCape Partners GP II, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P.

Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. Each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held of record by HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners II, L.P., HighCape Partners QP II, L.P., and Elutia PIPE Investment, LP.

Mr. Rakin may be deemed to beneficially own the securities held of record by the Kevin L. Rakin Irrevocable Trust. Each of the Reporting Persons disclaims beneficial ownership of the securities held by the other Reporting Persons.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

The responses to Items 3, 4 and 5 and Exhibits 2 through 3 are hereby incorporated herein.

Item 7. Material to Be Filed as Exhibits.

Item 7 of the Statement is hereby further amended to add the following exhibits:

Exhibit 1	Joint Filing Agreement.

Exhibit 2	Securities Purchase Agreement, dated September 18, 2023, by and among Elutia Inc. and the Investors named therein (attached as Exhibit 10.1 to the Form 8-K filed by Elutia, Inc. on September 21, 2023 and incorporated herein by reference).

Exhibit 3	Registration Rights Agreement, dated September 21, 2023, by and among Elutia Inc. and the Investors named therein (attached as Exhibit 10.2 to the Form 8-K filed by Elutia Inc. on September 21, 2023 and incorporated herein by reference).

SIGNATURES

After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date: October 6, 2023

	HIGHCAPE CAPITAL, L.P.

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS, L.P.

	By:	HighCape Partners GP, L.P., its general partner
	By:	HighCape Partners GP, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS QP, L.P.

	By:	HighCape Partners GP, L.P., its general partner
	By:	HighCape Partners GP, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS GP, LLC

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS GP, L.P.

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE CO-INVESTMENT VEHICLE I, LLC

	By:	HighCape Partners GP, L.P., its general partner
	By:	HighCape Partners GP, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE CO-INVESTMENT VEHICLE II, LLC

	By:	HighCape Partners GP, L.P., its general partner
	By:	HighCape Partners GP, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE CAPITAL, LLC

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS II, L.P.

	By:	HighCape Partners GP II, L.P., its general partner
	By:	HighCape Partners GP II, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS QP II, L.P.

	By:	HighCape Partners GP II, L.P., its general partner
	By:	HighCape Partners GP II, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS GP II, L.P.

	By:	HighCape Partners GP II, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	HIGHCAPE PARTNERS GP II, LLC

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	ELUTIA PIPE INVESTMENT, LP

	By:	HighCape Partners GP II, L.P., its general partner
	By:	HighCape Partners GP II, LLC, its general partner

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga
	Title: Managing Member

	By:	/s/ W. Matthew Zuga
	Name: W. Matthew Zuga

	By:	/s/ Kevin Rakin
	Name: Kevin Rakin

Get the next $AZYO alert in real time by email

SEC Form SC 13D/A filed by Aziyo Biologics Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for $AZYO

$AZYO Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Cowen & Co. reiterated coverage on Aziyo Biologics with a new price target

$AZYO Financials

Live finance-specific insights

Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company

Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

Aziyo Biologics Reports Highest Sales and Gross Profit in Company History

$AZYO Press Releases

Fastest customizable press release news feed in the world

Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices

Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures

$AZYO Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Mills C Randal

SEC Form 4 filed by Ferguson Matthew

SEC Form 4 filed by Williams Michelle Leroux

$AZYO Leadership Updates

Live Leadership Updates

Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors

Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer

Aziyo Biologics Appoints Peter G. Edwards as General Counsel

$AZYO Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Aziyo Biologics Inc.

SEC Form SC 13G/A filed by Aziyo Biologics Inc. (Amendment)

SEC Form SC 13D/A filed by Aziyo Biologics Inc. (Amendment)

$AZYO Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Highcape Capital, Llc bought 2,837,128 shares (SEC Form 4)

Highcape Capital, L.P. bought 2,837,128 shares (SEC Form 4)

$AZYO SEC Filings

$AZYO Market Insights

Live Market Insights

SEC Form 424B3 filed by Aziyo Biologics Inc.

Aziyo Biologics Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

SEC Form S-8 filed by Aziyo Biologics Inc.

Cantor Fitzgerald Reiterates Overweight on Aziyo Biologics, Maintains $8 Price Target

Aziyo Biologics Rebrands As Elutia To Reflect Strategic Focus On Drug Eluting Biomatrices; Company To Begin Trading Under New Ticker Symbol "ELUT"

Aziyo Biologics Announces Publication Of A CanGaroo Case Study Demonstrating Bioenvelope Benefits For Reoperative Procedures

Recent Analyst Ratings for
$AZYO

$AZYO
Analyst Ratings

$AZYO
Financials

$AZYO
Press Releases

$AZYO
Insider Trading

$AZYO
Leadership Updates

$AZYO
Large Ownership Changes

$AZYO
Insider Purchases

$AZYO
SEC Filings

$AZYO
Market Insights